1
|
de Kort FA, Coenen M, Weaver NA, Kuijf HJ, Aben HP, Bae HJ, Bordet R, Cammà G, Chen CP, Dewenter A, Duering M, Fang R, van der Giessen RS, Hamilton OK, Hilal S, Huenges Wajer IM, Kan CN, Kim J, Kim BJ, Köhler S, de Kort PL, Koudstaal PJ, Lim JS, Lopes R, Mok VC, Staals J, Venketasubramanian N, Verhagen CM, Verhey FR, Wardlaw JM, Xu X, Yu KH, Biesbroek JM, Biessels GJ. White Matter Hyperintensity Volume and Poststroke Cognition: An Individual Patient Data Pooled Analysis of 9 Ischemic Stroke Cohort Studies. Stroke 2023; 54:3021-3029. [PMID: 37901947 PMCID: PMC10664782 DOI: 10.1161/strokeaha.123.044297] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 09/14/2023] [Accepted: 09/22/2023] [Indexed: 10/31/2023]
Abstract
BACKGROUND White matter hyperintensities (WMH) are associated with cognitive dysfunction after ischemic stroke. Yet, uncertainty remains about affected domains, the role of other preexisting brain injury, and infarct types in the relation between WMH burden and poststroke cognition. We aimed to disentangle these factors in a large sample of patients with ischemic stroke from different cohorts. METHODS We pooled and harmonized individual patient data (n=1568) from 9 cohorts, through the Meta VCI Map consortium (www.metavcimap.org). Included cohorts comprised patients with available magnetic resonance imaging and multidomain cognitive assessment <15 months poststroke. In this individual patient data meta-analysis, linear mixed models were used to determine the association between WMH volume and domain-specific cognitive functioning (Z scores; attention and executive functioning, processing speed, language and verbal memory) for the total sample and stratified by infarct type. Preexisting brain injury was accounted for in the multivariable models and all analyses were corrected for the study site as a random effect. RESULTS In the total sample (67 years [SD, 11.5], 40% female), we found a dose-dependent inverse relationship between WMH volume and poststroke cognitive functioning across all 4 cognitive domains (coefficients ranging from -0.09 [SE, 0.04, P=0.01] for verbal memory to -0.19 [SE, 0.03, P<0.001] for attention and executive functioning). This relation was independent of acute infarct volume and the presence of lacunes and old infarcts. In stratified analyses, the relation between WMH volume and domain-specific functioning was also largely independent of infarct type. CONCLUSIONS In patients with ischemic stroke, increasing WMH volume is independently associated with worse cognitive functioning across all major domains, regardless of old ischemic lesions and infarct type.
Collapse
Affiliation(s)
- Floor A.S. de Kort
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (F.A.S.d.K., M.C., N.A.W., G.C., I.M.C.H.W., C.M.V., J.M.B., G.J.B.)
| | - Mirthe Coenen
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (F.A.S.d.K., M.C., N.A.W., G.C., I.M.C.H.W., C.M.V., J.M.B., G.J.B.)
| | - Nick A. Weaver
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (F.A.S.d.K., M.C., N.A.W., G.C., I.M.C.H.W., C.M.V., J.M.B., G.J.B.)
| | - Hugo J. Kuijf
- Image Sciences Institute, University Medical Center Utrecht, the Netherlands (H.J.K.)
| | - Hugo P. Aben
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands (H.P.A., P.L.M.d.K.)
| | - Hee-Joon Bae
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea (H.-J.B., J.K., B.J.K.)
| | - Régis Bordet
- Lille Neuroscience & Cognition (LilNCog) U1172, Université Lille, Inserm, CHU Lille, France (R.B., R.L.)
| | - Guido Cammà
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (F.A.S.d.K., M.C., N.A.W., G.C., I.M.C.H.W., C.M.V., J.M.B., G.J.B.)
| | - Christopher P.L.H. Chen
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore (C.P.L.H.C., S.H., C.N.K., X.X.)
- Memory, Aging and Cognition Center, National University Health System, Singapore (C.P.L.H.C., S.H., C.N.K., X.X.)
| | - Anna Dewenter
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Germany (A.D., M.D., R.F.)
| | - Marco Duering
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Germany (A.D., M.D., R.F.)
- Medical Image Analysis Center (MIAC) and Department of Biomedical Engineering, University of Basel, Switzerland (M.D.)
| | - Rong Fang
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Germany (A.D., M.D., R.F.)
| | - Ruben S. van der Giessen
- Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands (R.S.v.d.G., P.J.K.)
| | - Olivia K.L. Hamilton
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (O.K.L.H., J.M.W.)
- UK Dementia Research Institute at the University of Edinburgh, United Kingdom (O.K.L.H., J.M.W.)
- MRC/CSO Social and Public Health Sciences Unit, School of Health and Wellbeing, University of Glasgow, United Kingdom (O.K.L.H.)
| | - Saima Hilal
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore (C.P.L.H.C., S.H., C.N.K., X.X.)
- Memory, Aging and Cognition Center, National University Health System, Singapore (C.P.L.H.C., S.H., C.N.K., X.X.)
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System (S.H.)
| | - Irene M.C. Huenges Wajer
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (F.A.S.d.K., M.C., N.A.W., G.C., I.M.C.H.W., C.M.V., J.M.B., G.J.B.)
- Experimental Psychology, Helmholtz Institute, Utrecht University, the Netherlands (I.M.C.H.W.)
| | - Cheuk Ni Kan
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore (C.P.L.H.C., S.H., C.N.K., X.X.)
- Memory, Aging and Cognition Center, National University Health System, Singapore (C.P.L.H.C., S.H., C.N.K., X.X.)
| | - Jonguk Kim
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea (H.-J.B., J.K., B.J.K.)
| | - Beom Joon Kim
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea (H.-J.B., J.K., B.J.K.)
| | - Sebastian Köhler
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, the Netherlands (S.K., F.R.J.V.)
| | - Paul L.M. de Kort
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands (H.P.A., P.L.M.d.K.)
| | - Peter J. Koudstaal
- Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands (R.S.v.d.G., P.J.K.)
| | - Jae-Sung Lim
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea (J.-S.L.)
| | - Renaud Lopes
- Lille Neuroscience & Cognition (LilNCog) U1172, Université Lille, Inserm, CHU Lille, France (R.B., R.L.)
| | - Vincent C.T. Mok
- Division of Neurology, Department of Medicine and Therapeutics (V.C.T.M.), The Chinese University of Hong Kong
- Lau Tat-Chuen Research Centre of Brain Degenerative Diseases in Chinese, Li Ka Shing Institute of Health Sciences, Gerald Choa Neuroscience Institute, Lui Chi Woo Institute of Innovative Medicine (V.C.T.M.), The Chinese University of Hong Kong
| | - Julie Staals
- Department of Neurology, Maastricht University Medical Center, the Netherlands (J.S.)
| | | | - Charlotte M. Verhagen
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (F.A.S.d.K., M.C., N.A.W., G.C., I.M.C.H.W., C.M.V., J.M.B., G.J.B.)
| | - Frans R.J. Verhey
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, the Netherlands (S.K., F.R.J.V.)
| | - Joanna M. Wardlaw
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (O.K.L.H., J.M.W.)
- UK Dementia Research Institute at the University of Edinburgh, United Kingdom (O.K.L.H., J.M.W.)
| | - Xin Xu
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore (C.P.L.H.C., S.H., C.N.K., X.X.)
- Memory, Aging and Cognition Center, National University Health System, Singapore (C.P.L.H.C., S.H., C.N.K., X.X.)
| | - Kyung-Ho Yu
- Department of Neurology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea (K.-H.Y.)
| | - J. Matthijs Biesbroek
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (F.A.S.d.K., M.C., N.A.W., G.C., I.M.C.H.W., C.M.V., J.M.B., G.J.B.)
- Department of Neurology, Diakonessenhuis Hospital, Utrecht, the Netherlands (J.M.B.)
| | - Geert Jan Biessels
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (F.A.S.d.K., M.C., N.A.W., G.C., I.M.C.H.W., C.M.V., J.M.B., G.J.B.)
| |
Collapse
|
2
|
Exalto LG, Weaver NA, Kuijf HJ, Aben HP, Bae HJ, Best JG, Bordet R, Chen CP, van der Giessen RS, Godefroy O, Gyanwali B, Hamilton OK, Hilal S, Huenges Wajer IM, Kim J, Kappelle LJ, Kim BJ, Köhler S, de Kort PL, Koudstaal PJ, Lim JS, Makin SD, Mok VC, van Oostenbrugge RJ, Roussel M, Staals J, Valdés-Hernández MDC, Venketasubramanian N, Verhey FR, Wardlaw JM, Werring DJ, Xu X, van Zandvoort MJ, Biesbroek JM, Chappell FM, Biessels GJ. Sex Differences in Poststroke Cognitive Impairment: A Multicenter Study in 2343 Patients With Acute Ischemic Stroke. Stroke 2023; 54:2296-2303. [PMID: 37551589 PMCID: PMC10453354 DOI: 10.1161/strokeaha.123.042507] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Revised: 06/02/2023] [Accepted: 06/09/2023] [Indexed: 08/09/2023]
Abstract
BACKGROUND Poststroke cognitive impairment (PSCI) occurs in about half of stroke survivors. Cumulative evidence indicates that functional outcomes of stroke are worse in women than men. Yet it is unknown whether the occurrence and characteristics of PSCI differ between men and women. METHODS Individual patient data from 9 cohorts of patients with ischemic stroke were harmonized and pooled through the Meta-VCI-Map consortium (n=2343, 38% women). We included patients with visible symptomatic infarcts on computed tomography/magnetic resonance imaging and cognitive assessment within 15 months after stroke. PSCI was defined as impairment in ≥1 cognitive domains on neuropsychological assessment. Logistic regression analyses were performed to compare men to women, adjusted for study cohort, to obtain odds ratios for PSCI and individual cognitive domains. We also explored sensitivity and specificity of cognitive screening tools for detecting PSCI, according to sex (Mini-Mental State Examination, 4 cohorts, n=1814; Montreal Cognitive Assessment, 3 cohorts, n=278). RESULTS PSCI was found in 51% of both women and men. Men had a lower risk of impairment of attention and executive functioning (men: odds ratio, 0.76 [95% CI, 0.61-0.96]), and language (men: odds ratio, 0.67 [95% CI, 0.45-0.85]), but a higher risk of verbal memory impairment (men: odds ratio, 1.43 [95% CI, 1.17-1.75]). The sensitivity of Mini-Mental State Examination (<25) for PSCI was higher for women (0.53) than for men (0.27; P=0.02), with a lower specificity for women (0.80) than men (0.96; P=0.01). Sensitivity and specificity of Montreal Cognitive Assessment (<26.) for PSCI was comparable between women and men (0.91 versus 0.86; P=0.62 and 0.29 versus 0.28; P=0.86, respectively). CONCLUSIONS Sex was not associated with PSCI occurrence but affected domains differed between men and women. The latter may explain why sensitivity of the Mini-Mental State Examination for detecting PSCI was higher in women with a lower specificity compared with men. These sex differences need to be considered when screening for and diagnosing PSCI in clinical practice.
Collapse
Affiliation(s)
- Lieza G. Exalto
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (L.G.E., N.A.W., I.M.C.H.W., L.J.K., M.J.E.v.Z., J.M.B., G.J.B.)
| | - Nick A. Weaver
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (L.G.E., N.A.W., I.M.C.H.W., L.J.K., M.J.E.v.Z., J.M.B., G.J.B.)
| | - Hugo J. Kuijf
- Image Sciences Institute, University Medical Center Utrecht, the Netherlands (H.J.K.)
| | - Hugo P. Aben
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands (H.P.A., P.L.M.d.K.)
| | - Hee-Joon Bae
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea (H.-J.B., J.K., B.J.K.)
| | - Jonathan G. Best
- Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, United Kingdom (J.G.B., D.J.W.)
| | - Régis Bordet
- Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-Lille, France (R.B.)
| | - Christopher P.L.H. Chen
- Department of Pharmacology, National University of Singapore (C.P.L.H.C., S.H., X.X.)
- Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore (C.P.L.H.C., B.G., S.H., X.X.)
| | - Ruben S. van der Giessen
- Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands (R.S.v.d.G., P.J.K.)
| | - Olivier Godefroy
- Department of Neurology, Amiens University hospital, Laboratory of Functional Neurosciences, Jules Verne Picardy University, France (O.G., M.R.)
| | - Bibek Gyanwali
- Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore (C.P.L.H.C., B.G., S.H., X.X.)
| | - Olivia K.L. Hamilton
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (O.K.L.H., M.d.C.V.-H., J.M.W.)
- UK Dementia Research Institute at the University of Edinburgh, United Kingdom (O.K.L.H., M.d.C.V.-H., J.M.W.)
- MRC/CSO Social and Public Health Sciences Unit, School of Health and Wellbeing (O.K.L.H.), University of Glasgow, United Kingdom
| | - Saima Hilal
- Department of Pharmacology, National University of Singapore (C.P.L.H.C., S.H., X.X.)
- Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore (C.P.L.H.C., B.G., S.H., X.X.)
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System (S.H.)
| | - Irene M.C. Huenges Wajer
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (L.G.E., N.A.W., I.M.C.H.W., L.J.K., M.J.E.v.Z., J.M.B., G.J.B.)
- Experimental Psychology, Helmholtz Institute, Utrecht University, the Netherlands (I.M.C.H.W., M.J.E.v.Z.)
| | - Jonguk Kim
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea (H.-J.B., J.K., B.J.K.)
| | - L. Jaap Kappelle
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (L.G.E., N.A.W., I.M.C.H.W., L.J.K., M.J.E.v.Z., J.M.B., G.J.B.)
| | - Beom Joon Kim
- Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea (H.-J.B., J.K., B.J.K.)
| | - Sebastian Köhler
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, the Netherlands (S.K., F.R.J.V.)
| | - Paul L.M. de Kort
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands (H.P.A., P.L.M.d.K.)
| | - Peter J. Koudstaal
- Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands (R.S.v.d.G., P.J.K.)
| | - Jae-Sung Lim
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea (J.-S.L.)
| | - Stephen D.J. Makin
- Centre For Rural Health, Institute of Applied Health Sciences, University of Aberdeen, United Kingdom (S.D.J.M.)
| | - Vincent C.T. Mok
- Division of Neurology, Department of Medicine and Therapeutics (V.C.T.M.), The Chinese University of Hong Kong
- Therese Pei Fong Chow Research Centre for Prevention of Dementia, Margaret Kam Ling Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre (V.C.T.M.), The Chinese University of Hong Kong
| | | | - Martine Roussel
- Department of Neurology, Amiens University hospital, Laboratory of Functional Neurosciences, Jules Verne Picardy University, France (O.G., M.R.)
| | - Julie Staals
- Department of Neurology, Maastricht University Medical Center, the Netherlands (R.J.v.O., J.S.)
| | - Maria del C. Valdés-Hernández
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (O.K.L.H., M.d.C.V.-H., J.M.W.)
- UK Dementia Research Institute at the University of Edinburgh, United Kingdom (O.K.L.H., M.d.C.V.-H., J.M.W.)
| | | | - Frans R.J. Verhey
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, the Netherlands (S.K., F.R.J.V.)
| | - Joanna M. Wardlaw
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (O.K.L.H., M.d.C.V.-H., J.M.W.)
- UK Dementia Research Institute at the University of Edinburgh, United Kingdom (O.K.L.H., M.d.C.V.-H., J.M.W.)
| | - David J. Werring
- Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, United Kingdom (J.G.B., D.J.W.)
| | - Xin Xu
- Department of Pharmacology, National University of Singapore (C.P.L.H.C., S.H., X.X.)
- Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore (C.P.L.H.C., B.G., S.H., X.X.)
| | - Martine J.E. van Zandvoort
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (L.G.E., N.A.W., I.M.C.H.W., L.J.K., M.J.E.v.Z., J.M.B., G.J.B.)
- Experimental Psychology, Helmholtz Institute, Utrecht University, the Netherlands (I.M.C.H.W., M.J.E.v.Z.)
| | - J. Matthijs Biesbroek
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (L.G.E., N.A.W., I.M.C.H.W., L.J.K., M.J.E.v.Z., J.M.B., G.J.B.)
- Department of Neurology, Diakonessenhuis Hospital, Utrecht, the Netherlands (J.M.B.)
| | - Francesca M. Chappell
- Social and Public Health Sciences Unit (F.M.C.), University of Glasgow, United Kingdom
| | - Geert Jan Biessels
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, the Netherlands (L.G.E., N.A.W., I.M.C.H.W., L.J.K., M.J.E.v.Z., J.M.B., G.J.B.)
| |
Collapse
|
3
|
Kandiah N, Choi SH, Hu CJ, Ishii K, Kasuga K, Mok VC. Current and Future Trends in Biomarkers for the Early Detection of Alzheimer's Disease in Asia: Expert Opinion. J Alzheimers Dis Rep 2022; 6:699-710. [PMID: 36606209 PMCID: PMC9741748 DOI: 10.3233/adr-220059] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Accepted: 10/23/2022] [Indexed: 11/16/2022] Open
Abstract
Alzheimer's disease (AD) poses a substantial healthcare burden in the rapidly aging Asian population. Early diagnosis of AD, by means of biomarkers, can lead to interventions that might alter the course of the disease. The amyloid, tau, and neurodegeneration (AT[N]) framework, which classifies biomarkers by their core pathophysiological features, is a biomarker measure of amyloid plaques and neurofibrillary tangles. Our current AD biomarker armamentarium, comprising neuroimaging biomarkers and cerebrospinal fluid biomarkers, while clinically useful, may be invasive and expensive and hence not readily available to patients. Several studies have also investigated the use of blood-based measures of established core markers for detection of AD, such as amyloid-β and phosphorylated tau. Furthermore, novel non-invasive peripheral biomarkers and digital biomarkers could potentially expand access to early AD diagnosis to patients in Asia. Despite the multiplicity of established and potential biomarkers in AD, a regional framework for their optimal use to guide early AD diagnosis remains lacking. A group of experts from five regions in Asia gathered at a meeting in March 2021 to review the current evidence on biomarkers in AD diagnosis and discuss best practice around their use, with the goal of developing practical guidance that can be implemented easily by clinicians in Asia to support the early diagnosis of AD. This article summarizes recent key evidence on AD biomarkers and consolidates the experts' insights into the current and future use of these biomarkers for the screening and early diagnosis of AD in Asia.
Collapse
Affiliation(s)
- Nagaendran Kandiah
- Dementia Research Centre (Singapore), Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore,Correspondence to: Nagaendran Kandiah, Dementia Research Centre, Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, Singapore 308232. Tel.: +65 6592 2653; Fax: +65 6339 2889; E-mail: ; ORCID: 0000-0001-9244-4298
| | - Seong Hye Choi
- Department of Neurology, Inha University School of Medicine, Incheon, Republic of Korea
| | - Chaur-Jong Hu
- Department of Neurology, Dementia Center, Shuang Ho Hospital, College of Medicine, Taipei Medical University, Taipei, Taiwan
| | - Kenji Ishii
- Team for Neuroimaging Research, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
| | - Kensaku Kasuga
- Department of Molecular Genetics, Center for Bioresources, Brain Research Institute, Niigata University, Niigata, Japan
| | - Vincent C.T. Mok
- Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China,Li Ka Shing Institute of Health Sciences, Gerald Choa Neuroscience Institute, Lui Che Woo Institute of Innovative Medicine, Therese Pei Fong Chow Research Centre for Prevention of Dementia, The Chinese University of Hong Kong, Hong Kong, China
| |
Collapse
|
4
|
Cao H, Zhou X, Chen Y, Ip FC, Chen Y, Lai NC, Lo RM, Tong EP, Mok VC, Kwok TC, Fu AK, Ip NY. Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer’s Disease Risk. J Alzheimers Dis 2022; 86:1861-1873. [PMID: 35253752 PMCID: PMC9108557 DOI: 10.3233/jad-215311] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Background: Genetic studies reveal that single-nucleotide polymorphisms (SNPs) of SPI1 are associated with Alzheimer’s disease (AD), while their effects in the Chinese population remain unclear. Objective: We aimed to examine the AD-association of SPI1 SNPs in the Chinese population and investigate the underlying mechanisms of these SNPs in modulating AD risk. Methods: We conducted a genetic analysis of three SPI1 SNPs (i.e., rs1057233, rs3740688, and rs78245530) in a Chinese cohort (n = 333 patients with AD, n = 721 normal controls). We also probed public European-descent AD cohorts and gene expression datasets to investigate the putative functions of those SNPs. Results: We showed that SPI1 SNP rs3740688 is significantly associated with AD in the Chinese population (odds ratio [OR] = 0.72 [0.58–0.89]) and identified AD-protective SPI1 haplotypes β (tagged by rs1057233 and rs3740688) and γ (tagged by rs3740688 and rs78245530). Specifically, haplotypes β and γ are associated with decreased SPI1 gene expression level in the blood and brain tissues, respectively. The regulatory roles of these haplotypes are potentially mediated by changes in miRNA binding and the epigenetic landscape. Our results suggest that the AD-protective SPI1 haplotypes regulate pathways involved in immune and neuronal functions. Conclusion: This study is the first to report a significant association of SPI1 with AD in the Chinese population. It also identifies SPI1 haplotypes that are associated with SPI1 gene expression and decreased AD risk.
Collapse
Affiliation(s)
- Han Cao
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China
| | - Xiaopu Zhou
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China
| | - Yu Chen
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China
- Chinese Academy of Sciences Key Laboratory of Brain Connectome and Manipulation, Shenzhen Key Laboratory of Translational Research for Brain Diseases, The Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences; Shenzhen–Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, Shenzhen, Guangdong, China
| | - Fanny C.F. Ip
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China
| | - Yuewen Chen
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China
- Chinese Academy of Sciences Key Laboratory of Brain Connectome and Manipulation, Shenzhen Key Laboratory of Translational Research for Brain Diseases, The Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences; Shenzhen–Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, Shenzhen, Guangdong, China
| | - Nicole C.H. Lai
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
| | - Ronnie M.N. Lo
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
| | - Estella P.S. Tong
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
| | - Vincent C.T. Mok
- Gerald Choa Neuroscience Centre, Lui Che Woo Institute of Innovative Medicine, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, China
| | - Timothy C.Y. Kwok
- Therese Pei Fong Chow Research Centre for Prevention of Dementia, Division of Geriatrics, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, China
| | - Amy K.Y. Fu
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China
| | - Nancy Y. Ip
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China
| | | |
Collapse
|
5
|
Cai Y, Mok VC, Liu W, Fan X, Shi L, Au LW. Association between cerebral small‐vessel disease and Alzheimer’s disease pathologies. Alzheimers Dement 2021. [DOI: 10.1002/alz.052880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Yuan Cai
- The Chinese University of Hong Kong Hong Kong China
| | | | - Wanting Liu
- The Chinese University of Hong Kong Hong Kong China
| | - Xiang Fan
- The Chinese University of Hong Kong Hong Kong China
| | - Lin Shi
- The Chinese University of Hong Kong Hong Kong China
| | - Lisa W.C. Au
- Lui Che Woo Institute of Innovative Medicine Hong Kong China
| |
Collapse
|
6
|
Jiang Y, Zhou X, Ip FC, Chan P, Chen Y, Lai NCH, Cheung K, Lo RM, Tong EP, Wong BW, Chan AL, Mok VC, Kwok TC, Mok KY, Hardy J, Zetterberg H, Fu AK, Ip NY. A high‐performance biomarker panel for Alzheimer’s disease screening and staging identified by large‐scale plasma proteomic profiling. Alzheimers Dement 2021. [DOI: 10.1002/alz.056099] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Yuanbing Jiang
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
| | - Xiaopu Zhou
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science and Technology Parks Hong Kong China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen Guangdong China
| | - Fanny C.F. Ip
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science and Technology Parks Hong Kong China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen Guangdong China
| | - Philip Chan
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
| | - Yu Chen
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science and Technology Parks Hong Kong China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen Guangdong China
- The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong China
| | - Nicole Chit Hang Lai
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
| | - Kit Cheung
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
| | - Ronnie M.N. Lo
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
| | - Estella Pui‐Sze Tong
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
| | - Bonnie W.Y. Wong
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
| | - Andrew L.T. Chan
- Divisions of Neurology and Geriatrics, Department of Medicine, Queen Elizabeth Hospital Hong Kong China
| | - Vincent C.T. Mok
- Gerald Choa Neuroscience Centre, Lui Che Woo Institute of Innovative Medicine, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong Hong Kong China
| | - Timothy C.Y. Kwok
- Therese Pei Fong Chow Research Centre for Prevention of Dementia, Division of Geriatrics, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin Hong Kong China
| | - Kin Y. Mok
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science and Technology Parks Hong Kong China
- Department of Neurodegenerative Disease, UCL Institute of Neurology London United Kingdom
- UK Dementia Research Institute at UCL London United Kingdom
| | - John Hardy
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science and Technology Parks Hong Kong China
- Department of Neurodegenerative Disease, UCL Institute of Neurology London United Kingdom
- UK Dementia Research Institute at UCL London United Kingdom
| | - Henrik Zetterberg
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science and Technology Parks Hong Kong China
- UK Dementia Research Institute at UCL London United Kingdom
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital Mölndal Sweden
- Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square London United Kingdom
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg Mölndal Sweden
| | - Amy K.Y. Fu
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science and Technology Parks Hong Kong China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen Guangdong China
| | - Nancy Y. Ip
- Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science and Technology Parks Hong Kong China
- Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science, Shenzhen Guangdong China
- Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon Hong Kong China
| |
Collapse
|
7
|
Liu W, Luo Y, Shi L, Mok VC. Differentiation of dementia with Lewy bodies from normal elderly and Alzheimer’s disease: A DLB Resemblance Atrophy Index. Alzheimers Dement 2021. [DOI: 10.1002/alz.052937] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Wanting Liu
- The Chinese University of Hong Kong Hong Kong China
| | - Yishan Luo
- BrainNow Research Institute Shenzhen China
| | - Lin Shi
- The Chinese University of Hong Kong Hong Kong China
- BrainNow Research Institute Shenzhen China
| | | | | |
Collapse
|
8
|
Fan X, Zhao L, Liu W, Cai Y, Luo Y, Shi L, Mok VC. Alzheimer’s disease resemblance atrophy index in the identification of Alzheimer's disease with mild dementia. Alzheimers Dement 2021. [DOI: 10.1002/alz.052705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Xiang Fan
- The Chinese University of Hong Kong Hong Kong China
| | - Lei Zhao
- BrainNow Research Institute Shenzhen China
| | - Wanting Liu
- The Chinese University of Hong Kong Hong Kong China
| | - Yuan Cai
- The Chinese University of Hong Kong Hong Kong China
| | - Yishan Luo
- BrainNow Research Institute Shenzhen China
| | - Lin Shi
- The Chinese University of Hong Kong Hong Kong China
- BrainNow Research Institute Shenzhen China
| | | |
Collapse
|
9
|
Zhao L, Yiu B, Lam BY, Biesbroek JM, Luo Y, Shi L, Mok VC, Wong A. Mapping the contribution of clinical risk factors and MRI‐based imaging features to cognitive impairment in community elders. Alzheimers Dement 2020. [DOI: 10.1002/alz.039619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Lei Zhao
- BrainNow Research Institute Shenzhen China
| | - Brian Yiu
- The Chinese University of Hong Kong Shatin Hong Kong
| | | | | | - Yishan Luo
- BrainNow Research Institute Shenzhen China
| | - Lin Shi
- BrainNow Research Institute Shenzhen China
- The Chinese University of Hong Kong Shatin Hong Kong
| | | | - Adrian Wong
- Department of Medicine and Therapeutics Division of Neurology The Chinese University of Hong Kong Shatin Hong Kong
| |
Collapse
|
10
|
Zhou X, Chen Y, Lai NCH, Li YT, Kwok TC, Mok VC, Zhang Y, Ma S, Liu S, Chen Y, Tong EP, Ip FC, Mok KY, Hardy J, Fu AK, Ip NY. Evaluation of genetic risk for Alzheimer’s disease in the Hong Kong Chinese population. Alzheimers Dement 2020. [DOI: 10.1002/alz.045142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Xiaopu Zhou
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
| | - Yu Chen
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
- The Brain Cognition and Brain Disease Institute Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences Shenzhen Guangdong China
- Guangdong Provincial Key Laboratory of Brain Science Disease and Drug Development HKUST Shenzhen Research Institute Shenzhen Guangdong China
- Shenzhen‐Hong Kong Institute of Brain Science‐Shenzhen Fundamental Research Institutions Shenzhen Guangdong China
| | - Nicole Chit Hang Lai
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
| | - Yuen Tung Li
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
| | - Timothy C.Y. Kwok
- Therese Pei Fong Chow Research Centre for Prevention of Dementia Division of Geriatrics Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China
| | - Vincent C.T. Mok
- Gerald Choa Neuroscience Centre Lui Che Woo Institute of Innovative Medicine Therese Pei Fong Chow Research Centre for Prevention of Dementia Division of Neurology Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China
| | - Yulin Zhang
- Guangdong Provincial Key Laboratory of Brain Science Disease and Drug Development HKUST Shenzhen Research Institute Shenzhen Guangdong China
| | - Shuangshuang Ma
- Guangdong Provincial Key Laboratory of Brain Science Disease and Drug Development HKUST Shenzhen Research Institute Shenzhen Guangdong China
| | - Saijuan Liu
- Guangdong Provincial Key Laboratory of Brain Science Disease and Drug Development HKUST Shenzhen Research Institute Shenzhen Guangdong China
| | - Yuewen Chen
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
- The Brain Cognition and Brain Disease Institute Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences Shenzhen Guangdong China
- Guangdong Provincial Key Laboratory of Brain Science Disease and Drug Development HKUST Shenzhen Research Institute Shenzhen Guangdong China
- Shenzhen‐Hong Kong Institute of Brain Science‐Shenzhen Fundamental Research Institutions Shenzhen Guangdong China
| | - Estella Pui‐Sze Tong
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
| | - Fanny C.F. Ip
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
| | - Kin Y. Mok
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
- Institute of Neurology University College London London United Kingdom
| | - John Hardy
- Institute of Neurology University College London London United Kingdom
- Institute for Advanced Study The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
| | - Amy K.Y. Fu
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
- Guangdong Provincial Key Laboratory of Brain Science Disease and Drug Development HKUST Shenzhen Research Institute Shenzhen Guangdong China
- Shenzhen‐Hong Kong Institute of Brain Science‐Shenzhen Fundamental Research Institutions Shenzhen Guangdong China
| | - Nancy Y. Ip
- Division of Life Science State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center The Hong Kong University of Science and Technology Clear Water Bay Kowloon Hong Kong China
- Guangdong Provincial Key Laboratory of Brain Science Disease and Drug Development HKUST Shenzhen Research Institute Shenzhen Guangdong China
- Shenzhen‐Hong Kong Institute of Brain Science‐Shenzhen Fundamental Research Institutions Shenzhen Guangdong China
| |
Collapse
|
11
|
Zhao L, Yiu B, Lam BY, Biesbroek JM, Luo Y, Shi L, Mok VC, Wong A. Mapping the contributing factors of depression in community elders. Alzheimers Dement 2020. [DOI: 10.1002/alz.037441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Lei Zhao
- BrainNow Research Institute Shenzhen China
| | - Brian Yiu
- The Chinese University of Hong Kong Shatin Hong Kong
| | | | | | - Yishan Luo
- BrainNow Research Institute Shenzhen China
| | - Lin Shi
- BrainNow Research Institute Shenzhen China
- The Chinese University of Hong Kong Shatin Hong Kong
| | | | - Adrian Wong
- Department of Medicine and Therapeutics Division of Neurology The Chinese University of Hong Kong Shatin Hong Kong
| |
Collapse
|
12
|
Au LW, Kwan P, Mok VC. Transcranial pulse stimulation in Chinese patients with Alzheimer’s disease. Alzheimers Dement 2020. [DOI: 10.1002/alz.041481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Lisa W.C. Au
- The Chinese University of Hong Kong Hong Kong China
- Gerald Choa Neuroscience Centre Hong Kong China
- Therese Pei Fong Chow Research Centre for Prevention of Dementia Hong Kong China
- Lui Che Woo Institute of Innovative Medicine Hong Kong China
| | - Pauline Kwan
- The Chinese University of Hong Kong Hong Kong China
- Gerald Choa Neuroscience Centre Hong Kong China
- Therese Pei Fong Chow Research Centre for Prevention of Dementia Hong Kong China
- Lui Che Woo Institute of Innovative Medicine Hong Kong China
| | - Vincent C.T. Mok
- The Chinese University of Hong Kong Hong Kong China
- Gerald Choa Neuroscience Centre Hong Kong China
- Therese Pei Fong Chow Research Centre for Prevention of Dementia Hong Kong China
- Lui Che Woo Institute of Innovative Medicine Hong Kong China
| |
Collapse
|
13
|
Liu W, Au LW, Abrigo J, Luo Y, Wong A, Kwan P, Ma AHW, Ng AYT, Chen S, Leung EY, Ho CL, Chu WC, Ko H, Shi L, Mok VC. MRI‐based automated volumetric segmentation tool in the detection of early Alzheimer’s disease. Alzheimers Dement 2020. [DOI: 10.1002/alz.042340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Wanting Liu
- Gerald Choa Neuroscience Centre Therese Pei Fong Chow Research Centre for Prevention of Dementia Lui Che Woo Institute of Innovative Medicine Chinese University of Hong Kong Prince of Wales Hospital Shatin Hong Kong
| | - Lisa W.C. Au
- Lui Che Woo Institute of Innovative Medicine Hong Kong China
| | - Jill Abrigo
- The Chinese University of Hong Kong Shatin Hong Kong
| | - Yishan Luo
- BrainNow Research Institute Shenzhen China
| | - Adrain Wong
- Gerald Choa Neuroscience Centre Therese Pei Fong Chow Research Centre for Prevention of Dementia Lui Che Woo Institute of Innovative Medicine Chinese University of Hong Kong Prince of Wales Hospital Shatin Hong Kong
| | - Pauline Kwan
- Lui Che Woo Institute of Innovative Medicine Hong Kong China
| | - Alison Hon Wing Ma
- Gerald Choa Neuroscience Centre Therese Pei Fong Chow Research Centre for Prevention of Dementia Lui Che Woo Institute of Innovative Medicine Chinese University of Hong Kong Prince of Wales Hospital Shatin Hong Kong
| | - Anthea Yee Tung Ng
- Gerald Choa Neuroscience Centre Therese Pei Fong Chow Research Centre for Prevention of Dementia Lui Che Woo Institute of Innovative Medicine The Chinese University of Hong Kong Prince of Wales Hospital Hong Kong China
| | - Sirong Chen
- Hong Kong Sanatorium & Hospital Happy Valley Hong Kong
| | | | - Chi Lai Ho
- Hong Kong Sanatorium & Hospital Happy Valley Hong Kong
| | | | - Ho Ko
- Gerald Choa Neuroscience Centre Therese Pei Fong Chow Research Centre for Prevention of Dementia Lui Che Woo Institute of Innovative Medicine The Chinese University of Hong Kong Prince of Wales Hospital Hong Kong China
| | - Lin Shi
- The Chinese University of Hong Kong Shatin Hong Kong
| | | |
Collapse
|
14
|
Zhao L, Liu W, Luo Y, Kung WK, Xiong L, Mok VC, Shi L. Visual rating and automated brain volumetry for medial temporal lobe atrophy in differential diagnosis and early detection of Alzheimer’s disease. Alzheimers Dement 2020. [DOI: 10.1002/alz.041374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Lei Zhao
- BrainNow Research Institute Shenzhen China
| | - Wenyan Liu
- BrainNow Research Institute Shenzhen China
| | - Yishan Luo
- BrainNow Research Institute Shenzhen China
| | | | - Li Xiong
- BrainNow Research Institute Shenzhen China
- Shenzhen Research Institute The Chinese University of Hong Kong Shenzhen China
| | | | - Lin Shi
- BrainNow Research Institute Shenzhen China
- The Chinese University of Hong Kong Shatin Hong Kong
| |
Collapse
|
15
|
Biesbroek JM, Lam BY, Zhao L, Tang Y, Wang Z, Abrigo J, Chu WW, Wong A, Shi L, Kuijf HJ, Biessels GJ, Mok VC. High white matter hyperintensity burden in strategic white matter tracts relates to worse global cognitive performance in community-dwelling individuals. J Neurol Sci 2020; 414:116835. [DOI: 10.1016/j.jns.2020.116835] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2020] [Revised: 03/29/2020] [Accepted: 04/10/2020] [Indexed: 11/26/2022]
|
16
|
Weaver NA, Zhao L, Biesbroek JM, Kuijf HJ, Aben HP, Bae HJ, Caballero MÁ, Chappell FM, Chen CP, Dichgans M, Duering M, Georgakis MK, van der Giessen RS, Gyanwali B, Hamilton OK, Hilal S, vom Hofe EM, de Kort PL, Koudstaal PJ, Lam BY, Lim JS, Makin SD, Mok VC, Shi L, Valdés Hernández MC, Venketasubramanian N, Wardlaw JM, Wollenweber FA, Wong A, Xin X, Biessels GJ. The Meta VCI Map consortium for meta-analyses on strategic lesion locations for vascular cognitive impairment using lesion-symptom mapping: Design and multicenter pilot study. Alzheimers Dement (Amst) 2019; 11:310-326. [PMID: 31011619 PMCID: PMC6465616 DOI: 10.1016/j.dadm.2019.02.007] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
INTRODUCTION The Meta VCI Map consortium performs meta-analyses on strategic lesion locations for vascular cognitive impairment using lesion-symptom mapping. Integration of data from different cohorts will increase sample sizes, to improve brain lesion coverage and support comprehensive lesion-symptom mapping studies. METHODS Cohorts with available imaging on white matter hyperintensities or infarcts and cognitive testing were invited. We performed a pilot study to test the feasibility of multicenter data processing and analysis and determine the benefits to lesion coverage. RESULTS Forty-seven groups have joined Meta VCI Map (stroke n = 7800 patients; memory clinic n = 4900; population-based n = 14,400). The pilot study (six ischemic stroke cohorts, n = 878) demonstrated feasibility of multicenter data integration (computed tomography/magnetic resonance imaging) and achieved marked improvement of lesion coverage. DISCUSSION Meta VCI Map will provide new insights into the relevance of vascular lesion location for cognitive dysfunction. After the successful pilot study, further projects are being prepared. Other investigators are welcome to join.
Collapse
Affiliation(s)
- Nick A. Weaver
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Lei Zhao
- BrainNow Medical Technology Limited, Hong Kong Science and Technology Park, Shatin, Hong Kong SAR, China
| | - J. Matthijs Biesbroek
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Hugo J. Kuijf
- Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Hugo P. Aben
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands
| | - Hee-Joon Bae
- Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
| | - Miguel Á.A. Caballero
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
- German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
| | - Francesca M. Chappell
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
- UK Dementia Research Institute at the University of Edinburgh, Edinburgh, United Kingdom
| | - Christopher P.L.H. Chen
- Department of Pharmacology, National University of Singapore, Singapore, Singapore
- Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore
| | - Martin Dichgans
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
- German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
| | - Marco Duering
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
| | - Marios K. Georgakis
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
| | | | - Bibek Gyanwali
- Department of Pharmacology, National University of Singapore, Singapore, Singapore
- Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore
| | - Olivia K.L. Hamilton
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
- UK Dementia Research Institute at the University of Edinburgh, Edinburgh, United Kingdom
| | - Saima Hilal
- Department of Pharmacology, National University of Singapore, Singapore, Singapore
- Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore
- Departments of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Elise M. vom Hofe
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Paul L.M. de Kort
- Department of Neurology, Elisabeth Tweesteden Hospital, Tilburg, the Netherlands
| | - Peter J. Koudstaal
- Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Bonnie Y.K. Lam
- Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
| | - Jae-Sung Lim
- Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea
| | - Stephen D.J. Makin
- Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
| | - Vincent C.T. Mok
- Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
| | - Lin Shi
- BrainNow Medical Technology Limited, Hong Kong Science and Technology Park, Shatin, Hong Kong SAR, China
- Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong SAR, China
| | - Maria C. Valdés Hernández
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
- UK Dementia Research Institute at the University of Edinburgh, Edinburgh, United Kingdom
| | | | - Joanna M. Wardlaw
- Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
- UK Dementia Research Institute at the University of Edinburgh, Edinburgh, United Kingdom
| | - Frank A. Wollenweber
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
| | - Adrian Wong
- Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
| | - Xu Xin
- Department of Pharmacology, National University of Singapore, Singapore, Singapore
- Memory, Aging and Cognition Center, National University Health System, Singapore, Singapore
| | - Geert Jan Biessels
- Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands
| |
Collapse
|
17
|
Smith EE, Biessels GJ, De Guio F, de Leeuw FE, Duchesne S, Düring M, Frayne R, Ikram MA, Jouvent E, MacIntosh BJ, Thrippleton MJ, Vernooij MW, Adams H, Backes WH, Ballerini L, Black SE, Chen C, Corriveau R, DeCarli C, Greenberg SM, Gurol ME, Ingrisch M, Job D, Lam BY, Launer LJ, Linn J, McCreary CR, Mok VC, Pantoni L, Pike GB, Ramirez J, Reijmer YD, Romero JR, Ropele S, Rost NS, Sachdev PS, Scott CJ, Seshadri S, Sharma M, Sourbron S, Steketee RM, Swartz RH, van Oostenbrugge R, van Osch M, van Rooden S, Viswanathan A, Werring D, Dichgans M, Wardlaw JM. Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration. Alzheimers Dement (Amst) 2019; 11:191-204. [PMID: 30859119 PMCID: PMC6396326 DOI: 10.1016/j.dadm.2019.01.002] [Citation(s) in RCA: 53] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
INTRODUCTION Many consequences of cerebrovascular disease are identifiable by magnetic resonance imaging (MRI), but variation in methods limits multicenter studies and pooling of data. The European Union Joint Program on Neurodegenerative Diseases (EU JPND) funded the HARmoNizing Brain Imaging MEthodS for VaScular Contributions to Neurodegeneration (HARNESS) initiative, with a focus on cerebral small vessel disease. METHODS Surveys, teleconferences, and an in-person workshop were used to identify gaps in knowledge and to develop tools for harmonizing imaging and analysis. RESULTS A framework for neuroimaging biomarker development was developed based on validating repeatability and reproducibility, biological principles, and feasibility of implementation. The status of current MRI biomarkers was reviewed. A website was created at www.harness-neuroimaging.org with acquisition protocols, a software database, rating scales and case report forms, and a deidentified MRI repository. CONCLUSIONS The HARNESS initiative provides resources to reduce variability in measurement in MRI studies of cerebral small vessel disease.
Collapse
Affiliation(s)
- Eric E. Smith
- Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
- Department of Radiology, University of Calgary, Calgary, Alberta, Canada
- Hotchkiss Brain Institute, University of Calgary, Alberta, Canada
| | - Geert Jan Biessels
- Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, Netherlands
| | - François De Guio
- Department of Neurology, Lariboisière Hospital, University Paris Diderot, Paris, France
| | - Frank Erik de Leeuw
- Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Donders Center for Medical Neuroscience, Radboud University Medical Center, Nijmegen, Netherlands
| | - Simon Duchesne
- CERVO Research Center, Quebec Mental Health Institute, Québec, Canada
- Radiology Department, Université Laval, Québec, Canada
| | - Marco Düring
- Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-Universität LMU, Munich, Germany
- German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
| | - Richard Frayne
- Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
- Department of Radiology, University of Calgary, Calgary, Alberta, Canada
- Hotchkiss Brain Institute, University of Calgary, Alberta, Canada
- Seaman Family MR Centre, Foothills Medical Centre, Calgary, Alberta, Canada
| | - M. Arfan Ikram
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands
| | - Eric Jouvent
- Department of Neurology, Lariboisière Hospital, University Paris Diderot, Paris, France
| | - Bradley J. MacIntosh
- Heart and Stroke Foundation Canadian Partnership for Stroke Recovery, Department of Medical Biophysics, Sunnybrook Research Institute, University of Toronto, Ontario, Canada
| | - Michael J. Thrippleton
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
- Edinburgh Imaging, University of Edinburgh, Edinburgh, UK
- UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK
| | - Meike W. Vernooij
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Hieab Adams
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Walter H. Backes
- Department of Radiology & Nuclear Medicine, School for Mental Health & Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands
| | - Lucia Ballerini
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
- Edinburgh Imaging, University of Edinburgh, Edinburgh, UK
- UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK
| | - Sandra E. Black
- Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada
- Heart and Stroke Foundation Canadian Partnership for Stroke Recovery, Toronto, Ontario, Canada
- Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
| | - Christopher Chen
- Memory Aging and Cognition Centre, Department of Pharmacology, National University of Singapore, Singapore
| | - Rod Corriveau
- National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA
| | - Charles DeCarli
- Department of Neurology and Center for Neuroscience, University of California at Davis, Davis, CA, USA
| | - Steven M. Greenberg
- J. Philip Kistler Stroke Research Center, Stroke Service and Memory Disorders Unit, Massachusetts General Hospital, Boston, MA, USA
| | - M. Edip Gurol
- J. Philip Kistler Stroke Research Center, Stroke Service and Memory Disorders Unit, Massachusetts General Hospital, Boston, MA, USA
| | - Michael Ingrisch
- Department of Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany
| | - Dominic Job
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
- Edinburgh Imaging, University of Edinburgh, Edinburgh, UK
- UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK
| | - Bonnie Y.K. Lam
- Therese Pei Fong Chow Research Centre for Prevention of Dementia, Gerald Choa Neuroscience Centre, Lui Che Woo Institute of Innovative Medicine, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
| | - Lenore J. Launer
- National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
| | - Jennifer Linn
- Institute of Neuroradiology, University Hospital Carl Gustav Carus, Dresden, Germany
| | - Cheryl R. McCreary
- Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
- Department of Radiology, University of Calgary, Calgary, Alberta, Canada
- Seaman Family MR Centre, Foothills Medical Centre, Calgary, Alberta, Canada
| | - Vincent C.T. Mok
- Therese Pei Fong Chow Research Centre for Prevention of Dementia, Gerald Choa Neuroscience Centre, Lui Che Woo Institute of Innovative Medicine, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
| | - Leonardo Pantoni
- Luigi Sacco Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy
| | - G. Bruce Pike
- Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
- Department of Radiology, University of Calgary, Calgary, Alberta, Canada
- Hotchkiss Brain Institute, University of Calgary, Alberta, Canada
| | - Joel Ramirez
- Heart and Stroke Foundation Canadian Partnership for Stroke Recovery, Department of Medical Biophysics, Sunnybrook Research Institute, University of Toronto, Ontario, Canada
- Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada
| | - Yael D. Reijmer
- Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, Netherlands
| | - Jose Rafael Romero
- Department of Neurology, Boston University School of Medicine, Boston, MA, USA
- Framingham Heart Study, Framingham, MA, USA
| | - Stefan Ropele
- Department of Neurology, Medical University of Graz, Graz, Austria
| | - Natalia S. Rost
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA, USA
| | - Perminder S. Sachdev
- Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia
| | - Christopher J.M. Scott
- Heart and Stroke Foundation Canadian Partnership for Stroke Recovery, Department of Medical Biophysics, Sunnybrook Research Institute, University of Toronto, Ontario, Canada
- Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada
| | - Sudha Seshadri
- Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA
| | - Mukul Sharma
- Population Health Research Institute, Hamilton, Ontario, Canada
- Department of Medicine (Neurology) McMaster University, Hamilton, Ontario, Canada
| | - Steven Sourbron
- Imaging Biomarkers Group, Department of Biomedical Imaging Sciences, University of Leeds, Leeds, UK
| | - Rebecca M.E. Steketee
- Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Richard H. Swartz
- Department of Medicine (Neurology), University of Toronto, Toronto, Canada
- Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada
| | - Robert van Oostenbrugge
- Department of Neurology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands
| | - Matthias van Osch
- C.J. Gorter Center for high field MRI, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Sanneke van Rooden
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Anand Viswanathan
- J. Philip Kistler Stroke Research Center, Stroke Service and Memory Disorders Unit, Massachusetts General Hospital, Boston, MA, USA
| | - David Werring
- University College London Queen Square institute of Neurology, London, UK
| | - Martin Dichgans
- Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-Universität LMU, Munich, Germany
- German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
| | - Joanna M. Wardlaw
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
- Edinburgh Imaging, University of Edinburgh, Edinburgh, UK
- UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK
| |
Collapse
|
18
|
Liu W, Shi L, Abrigo J, Luo Y, Wong A, Au L, Kwan P, Wing Ma AH, Chen S, Leung EY, Ho CL, Chu WC, Mok VC. P3-371: HIPPOCAMPAL VOLUMETRY IN THE DETECTION OF AMYLOID POSITIVE SUBJECTIVE COGNITIVE COMPLAINTS AND MILD COGNITIVE IMPAIRMENT. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.3404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- Wanting Liu
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Lin Shi
- BrainNow Research Institute; Shenzhen China
- The Chinese University of Hong Kong; Shatin Hong Kong
| | - Jill Abrigo
- The Chinese University of Hong Kong; Shatin Hong Kong
| | - Yishan Luo
- BrainNow Research Institute; Shenzhen China
| | - Adrain Wong
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Lisa Au
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Pauline Kwan
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Alison Hon Wing Ma
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Sirong Chen
- Hong Kong Sanatorium and Hospital; Happy Valley Hong Kong
| | | | - Chi Lai Ho
- Hong Kong Sanatorium and Hospital; Happy Valley Hong Kong
| | | | - Vincent C.T. Mok
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| |
Collapse
|
19
|
Liu W, Shi L, Abrigo J, Luo Y, Wong A, Au L, Kwan P, Wing Ma AH, Chen S, Leung EY, Ho CL, Chu WC, Mok VC. IC-P-123: HIPPOCAMPAL VOLUMETRY IN THE DETECTION OF AMYLOID POSITIVE SUBJECTIVE COGNITIVE COMPLAINTS AND MILD COGNITIVE IMPAIRMENT. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4237] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Wanting Liu
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Lin Shi
- BrainNow Research Institute; Shenzhen China
- The Chinese University of Hong Kong; Shatin Hong Kong
| | - Jill Abrigo
- The Chinese University of Hong Kong; Shatin Hong Kong
| | - Yishan Luo
- BrainNow Research Institute; Shenzhen China
| | - Adrain Wong
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Lisa Au
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Pauline Kwan
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Alison Hon Wing Ma
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| | - Sirong Chen
- Hong Kong Sanatorium and Hospital; Happy Valley Hong Kong
| | | | - Chi Lai Ho
- Hong Kong Sanatorium and Hospital; Happy Valley Hong Kong
| | | | - Vincent C.T. Mok
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
| |
Collapse
|
20
|
Yu JT, Li JQ, Suckling J, Feng L, Pan A, Wang Y, Dong Q, Tan L, Mok VC, Aisen PS, Weiner MW. O1‐07‐06: PREVALENCE AND LONGITUDINAL CLINICAL OUTCOMES OF ALZHEIMER'S ATN BIOMARKER PROFILES: A LONGITUDINAL STUDY. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.4558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Jin-Tai Yu
- Huashan Hospital Fudan University Shanghai China
| | | | | | - Lei Feng
- National University of Singapore Singapore Singapore
| | - An Pan
- Huazhong University of Science and Technology Wuhan China
| | - Yanjiang Wang
- Department of Neurology, Daping Hospital Third Military Medical University Chongqing China
| | - Qiang Dong
- Huashan Hospital Fudan University Shanghai China
| | - Lan Tan
- Qingdao Municipal Hospital, School of Medicine Qingdao University Qingdao China
| | - Vincent C.T. Mok
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine The Chinese University of Hong Kong, Prince of Wales Hospital Shatin Hong Kong
| | - Paul S. Aisen
- Alzheimer's Therapeutic Research Institute San Diego CA USA
| | - Michael W. Weiner
- UCSF Department of Radiology and Biomedical Imaging San Francisco CA USA
| |
Collapse
|
21
|
Zhao L, Luo Y, Lew D, Mok VC, Shi L. P4-072: IDENTIFYING NORMAL SUBJECTS AT RISK OF PROGRESSION TO MILD COGNITIVE IMPAIRMENT WITH AUTOMATED BRAIN VOLUMETRY. Alzheimers Dement 2019. [DOI: 10.1016/j.jalz.2019.06.3732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- Lei Zhao
- BrainNow Research Institute; Shenzhen China
| | - Yishan Luo
- BrainNow Research Institute; Shenzhen China
| | - Darson Lew
- BrainNow Research Institute; Shenzhen China
- The Chinese University of Hong Kong; NT Hong Kong
| | - Vincent C.T. Mok
- The Chinese University of Hong Kong; NT Hong Kong
- Gerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine; The Chinese University of Hong Kong, Prince of Wales Hospital; Shatin Hong Kong
- Therese Pei Fong Chow Research Centre for Prevention of Dementia; The Chinese University of Hong Kong; Hong Kong Hong Kong
| | - Lin Shi
- BrainNow Research Institute; Shenzhen China
- The Chinese University of Hong Kong; Shatin Hong Kong
| | | |
Collapse
|
22
|
Lee D, Lam BY, Au L, Mok VC, Wong A. P2‐584: CHINESE INCENSE BURNING IS ASSOCIATED WITH SMALL BUT SIGNIFICANT DECLINE IN MULTIPLE COGNITIVE DOMAINS IN COMMUNITY ELDERLY PERSONS. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.1279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Dustin Lee
- Stony Brook UniversitySchool of MedicineNew YorkNYUSA
| | | | - Lisa Au
- The Chinese University of Hong KongHong KongHong Kong
- Therese Pei Fong Chow Research Centre for Prevention of DementiaThe Chinese University of Hong KongHong KongHong Kong
- Gerald Choa Neuroscience CentreThe Chinese University of Hong KongHong KongHong Kong
| | - Vincent C.T. Mok
- The Chinese University of Hong KongShatinHong Kong
- Therese Pei Fong Chow Research Centre for Prevention of DementiaThe Chinese University of Hong KongHong KongHong Kong
- Gerald Choa Neuroscience CentreThe Chinese University of Hong KongHong KongHong Kong
| | - Adrian Wong
- Therese Pei Fong Chow Research Centre for Prevention of DementiaThe Chinese University of Hong KongHong KongHong Kong
- The Chinese University of Hong KongShatinHong Kong
| |
Collapse
|
23
|
Zhao W, Luo Y, Zhao L, Mok VC, Sun Y, Shi L, Han Y. P3‐078: MACHINE LEARNING DIFFERENTIATES EARLY STAGES OF ALZHEIMER'S DISEASE FROM NORMAL AGING: A BRAIN MORPHOMETRY STUDY. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.1434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Weina Zhao
- XuanWu Hospital of Capital Medical UniversityBeijingChina
| | - Yishan Luo
- Hong Kong Science and Technology ParkHong KongHong Kong
| | - Lei Zhao
- The Chinese University of Hong KongHong KongHong Kong
| | | | - Yu Sun
- XuanWu Hospital of Capital Medical UniversityBeijingChina
| | - Lin Shi
- The Chinese University of Hong KongShatinHong Kong
| | - Ying Han
- XuanWu Hospital of Capital Medical UniversityBeijingChina
- Xuan Wu Hospital of Capital Medical UniversityCenter of Alzheimer's Disease, Beijing Institute for Brain DisordersBeijingChina
| |
Collapse
|
24
|
Ding D, Xiong Y, Zhao Q, Guo Q, Chu S, Chu WW, Luo J, Liang X, Zheng L, Hong Z, Wong LK, Mok VC. White Matter Hyperintensity Predicts the Risk of Incident Cognitive Decline in Community Dwelling Elderly. J Alzheimers Dis 2018; 61:1333-1341. [PMID: 29376875 DOI: 10.3233/jad-170876] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Ding Ding
- Institute of Neurology, Huashan Hospital, Fudan University, WHO Collaborating Center for Research and Training in Neurosciences, Shanghai, China
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Yunyun Xiong
- Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu Province, China
| | - Qianhua Zhao
- Institute of Neurology, Huashan Hospital, Fudan University, WHO Collaborating Center for Research and Training in Neurosciences, Shanghai, China
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Qihao Guo
- Institute of Neurology, Huashan Hospital, Fudan University, WHO Collaborating Center for Research and Training in Neurosciences, Shanghai, China
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Shuguang Chu
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China
- Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China
| | - Winnie W.C. Chu
- Department of Radiology and Organ Imaging, The Chinese University of Hong Kong, Shatin, Hong Kong, China
| | - Jianfeng Luo
- Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China
| | - Xiaoniu Liang
- Institute of Neurology, Huashan Hospital, Fudan University, WHO Collaborating Center for Research and Training in Neurosciences, Shanghai, China
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Li Zheng
- Institute of Neurology, Huashan Hospital, Fudan University, WHO Collaborating Center for Research and Training in Neurosciences, Shanghai, China
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Zhen Hong
- Institute of Neurology, Huashan Hospital, Fudan University, WHO Collaborating Center for Research and Training in Neurosciences, Shanghai, China
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Lawrence K.S. Wong
- Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China
- Department of Medicine and Therapeutics, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China
| | - Vincent C.T. Mok
- Department of Medicine and Therapeutics, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China
| |
Collapse
|
25
|
Tsoi KK, Chan JY, Hirai HW, Wong A, Mok VC, Lam LC, Kwok TC, Wong SY. Recall Tests Are Effective to Detect Mild Cognitive Impairment: A Systematic Review and Meta-analysis of 108 Diagnostic Studies. J Am Med Dir Assoc 2017; 18:807.e17-807.e29. [DOI: 10.1016/j.jamda.2017.05.016] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2017] [Revised: 05/17/2017] [Accepted: 05/18/2017] [Indexed: 11/25/2022]
|
26
|
Tsoi K, Chan JY, Hirai HW, Wong A, Mok VC, Kwok T, Wong SYS. [P3–298]: COGNITIVE TESTS TO DETECT MILD COGNITIVE IMPAIRMENT: A SYSTEMATIC REVIEW AND META‐ANALYSIS. Alzheimers Dement 2017. [DOI: 10.1016/j.jalz.2017.06.1512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Kelvin Tsoi
- The Chinese University of Hong KongShatinHong Kong
| | | | | | - Adrian Wong
- Chinese University of Hong KongShatinHong Kong
| | | | - Timothy Kwok
- The Chinese University of Hong KongShatinHong Kong
| | | |
Collapse
|
27
|
Wong A, Leung K, Mok VC. [P1–480]: CONVERSION OF SCORES FROM MMSE TO MOCA AND MOCA 5‐MINUTE PROTOCOL IN PATIENTS WITH STROKE OR TRANSIENT ISCHEMIC ATTACK. Alzheimers Dement 2017. [DOI: 10.1016/j.jalz.2017.06.496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Adrian Wong
- Chinese University of Hong KongShatinHong Kong
| | | | | |
Collapse
|
28
|
Wong GK, Lee A, Wong A, Ho FL, Leung SL, Zee BC, Poon WS, Siu DY, Abrigo JM, Mok VC. Clinically important difference of Stroke-Specific Quality of Life Scale for aneurysmal subarachnoid hemorrhage. J Clin Neurosci 2016; 33:209-212. [DOI: 10.1016/j.jocn.2016.05.029] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Accepted: 05/05/2016] [Indexed: 11/24/2022]
|
29
|
Wong A, Abrigo J, Shi L, Lam BY, Chu WC, Lo ES, Liu W, Mok VC. P2‐261: A Threshold of White Matter Hyperintensities Volume Ratio Doubling the Risk of Cognitive Decline in Patients with Stroke or Transient Ischemic Attack. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.1521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Adrian Wong
- The Chinese University of Hong KongHong KongHong Kong
| | - Jill Abrigo
- Chinese University of Hong KongHong KongHong Kong
| | - Lin Shi
- The Chinese University of Hong KongHong KongHong Kong
| | | | | | | | - Wenyan Liu
- The Chinese University of Hong KongHong KongHong Kong
| | | |
Collapse
|
30
|
Wong A, Lau AY, Lo ES, Tang M, Wang Z, Liu W, Tanner N, Chau N, Law LS, Shi L, Chu WC, Yang J, Xiong YY, Lam BY, Au L, Soo YO, Leung TW, Wong LK, Lam LC, Mok VC. O4‐12‐05: Regular Participation in Prestroke Leisure Activities Reduced Risks of Dementia and Improved Cognitive Functions after Stroke or Transient Ischemic Attack: Results from the Stride Study. Alzheimers Dement 2016. [DOI: 10.1016/j.jalz.2016.06.676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- Adrian Wong
- The Chinese University of Hong KongHong KongHong Kong
| | | | | | - Michael Tang
- The Chinese University of Hong KongHong KongHong Kong
| | - Zhaolu Wang
- The Chinese University of Hong KongHong KongHong Kong
| | - Wenyan Liu
- The Chinese University of Hong KongHong KongHong Kong
| | - Nicole Tanner
- The Chinese University of Hong KongHong KongHong Kong
| | - Natalie Chau
- The Chinese University of Hong KongHong KongHong Kong
| | | | - Lin Shi
- The Chinese University of Hong KongHong KongHong Kong
| | | | - Jie Yang
- Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University and Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and Ministry of Education of ChinaGuangzhouChina
| | - Yun-Yun Xiong
- Jinling Hospital, Nanjing University School of MedicineNanjingChina
| | | | - Lisa Au
- The Chinese University of Hong KongHong KongHong Kong
| | | | | | | | | | | |
Collapse
|
31
|
Affiliation(s)
- Adrian Wong
- From the Department of Medicine and Therapeutics, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China
| | - Lorraine S.N. Law
- From the Department of Medicine and Therapeutics, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China
| | - Wenyan Liu
- From the Department of Medicine and Therapeutics, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China
| | - Zhaolu Wang
- From the Department of Medicine and Therapeutics, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China
| | - Eugene S.K. Lo
- From the Department of Medicine and Therapeutics, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China
| | - Alexander Lau
- From the Department of Medicine and Therapeutics, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China
| | - Lawrence K.S. Wong
- From the Department of Medicine and Therapeutics, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China
| | - Vincent C.T. Mok
- From the Department of Medicine and Therapeutics, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China
| |
Collapse
|
32
|
Wong GK, Wong A, Zee BC, Poon WS, Chan MT, Gin T, Siu DY, Mok VC. Cognitive outcome in acute simvastatin treatment for aneurysmal subarachnoid hemorrhage: A propensity matched analysis. J Neurol Sci 2015; 358:58-61. [DOI: 10.1016/j.jns.2015.08.013] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2015] [Revised: 07/15/2015] [Accepted: 08/10/2015] [Indexed: 10/23/2022]
|
33
|
Zhu X, Chan DT, Lau CK, Poon WS, Mok VC, Chan AY, Wong LK, Yeung JH, Leung MC, Tang VY, Wong RK, Yeung C. Cost-Effectiveness of Subthalmic Nucleus Deep Brain Stimulation for the Treatment of Advanced Parkinson Disease in Hong Kong: A Prospective Study. World Neurosurg 2014; 82:987-93. [DOI: 10.1016/j.wneu.2014.08.051] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2014] [Accepted: 08/25/2014] [Indexed: 11/27/2022]
|
34
|
Affiliation(s)
- Zhaolu Wang
- From the Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
| | - Yannie O.Y. Soo
- From the Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
| | - Vincent C.T. Mok
- From the Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
| |
Collapse
|
35
|
Chan DT, Zhu XL, Yeung JH, Mok VC, Wong E, Lau C, Wong R, Lau C, Poon WS. Complications of Deep Brain Stimulation: A Collective Review. Asian J Surg 2009; 32:258-63. [DOI: 10.1016/s1015-9584(09)60404-8] [Citation(s) in RCA: 71] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
36
|
Chan DT, Mok VC, Poon WS, Hung KN, Zhu XL. Surgical management of Parkinson's disease: a critical review. Hong Kong Med J 2001; 7:34-9. [PMID: 11406674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023] Open
Abstract
Parkinson's disease is a progressive disabling movement disorder that is characterised by three cardinal symptoms: resting tremor, rigidity, and bradykinesia. Before the availability of effective medical treatment with levodopa and stereotactic neurosurgery, the objective of surgical management was to alleviate symptoms such as tremor at the expense of motor deficits. Levodopa was the first effective medical treatment for Parkinson's disease, and surgical treatment such as stereotactic thalamotomy became obsolete. After one decade of levodopa therapy, however, drug-induced dyskinesia had become a source of additional disability not amenable to medical treatment. Renewed interest in stereotactic functional neurosurgery to manage Parkinson's disease has been seen since the 1980s. Local experience of deep-brain stimulation is presented and discussed in this paper. Deep-brain stimulation of the subthalamic nucleus is an effective treatment for advanced Parkinson's disease, although evidence from randomised control trials is lacking.
Collapse
Affiliation(s)
- D T Chan
- Division of Neurosurgery, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
| | | | | | | | | |
Collapse
|